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Background: Toxoplasma gondii is a parasite that causes signiﬁcant disease in humans. Toxoplasmosis is nor-
mally asymptomatic, unless associated with congenital transmission, or in immunocompromised people.
Congenital transmission generally occurs at low frequencies. In this study, we use PCR to investigate possible
congenital transmission of T. gondii during pregnancy in a cohort of mothers from Libya.
Methods: Two hundred and seventy two pregnant women (producing 276 neonates) were recruited to obtain
umbilical cord tissue from their neonates at birth; DNA was extracted from that tissue and tested for T. gondii
DNA using two speciﬁc PCR protocols based on the sag 1 and sag 3 genes.
Results: Toxoplasma gondii DNA was detected in the umbilical cord DNA from 27 of the 276 neonates giving a
prevalence of 9.9% (95% CI 6.8–13.9%). Compared with more commonly reported rates of congenital trans-
mission of 0.1% of live births, this is high. There was no association of infection with unsuccessful pregnancy.
Conclusions: This study shows a high frequency presence of T. gondii DNA associated with neonatal tissue at
birth in this cohort of 276 neonates from Libya. Although PCR cannot detect living parasites, there is the possi-
bility that this indicates a higher than usual frequency of congenital transmission.
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Introduction
Toxoplasmosis is caused by the protozoan parasite Toxoplasma
gondii and is an important human and animal disease with a
worldwide distribution.1 The prevalence of infection in the
human population is estimated at 30% globally. However preva-
lence varies with values of 10–20% recorded in the UK, China
and US but exceeds 40% in some countries, for example, within
South America or continental Europe.2 Human infection is
acquired through contact with oocysts passed in faeces by the
deﬁnitive host, the cat, or by consuming the tissue cyst(s) found
in uncooked or undercooked meat. Congenital transmission,
from mother to baby, is also considered a route of transmission –
although is considered as rare in humans with occurrence in less
than 1 in 1000 live births.1,3–5 Toxoplasma infection is usually
asymptomatic. However, in pregnant women a novel infection
can cause congenital toxoplasmosis in the foetus, neonate and
developing child and some of them may also develop brain dis-
eases such as bipolar disorder and schizophrenia.4,6–9 Studies on
prevalence in pregnant women, for example in China,10 show
that the frequency of infection usually follows the general popu-
lation prevalence—in this example, averaging 10% in both cases.
However, chronic infection of the mother usually does not result
in transmission to the foetus and transmission is generally
thought to be related to seroconversion during pregnancy5 or
possibly, under some circumstances, reinfection of a chronic
infection.11
In humans, an estimated 10% of prenatally acquired infec-
tions result in abortion (i.e., spontaneous miscarriage) or neo-
natal death.12,13 Furthermore, an additional 10–23% of infected
newborns will show signs and symptoms present at birth such
as retinochoroiditis, intracranial calciﬁcations and hydroceph-
alus.12,14,15 It is these abnormalities that signiﬁcantly reduce
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the quality of life of children that survive prenatal infection of
the mother.3,5
While studies on congenital transmission in humans suggest
that it may occur rarely in the absence of infection during preg-
nancy, some recent studies in other species have, controversially,
proposed that congenital infection may be occurring much more
frequently than previously thought. A number of studies, con-
ducted over many years, using experimental infection of rodents
has shown that congenital infection can occur frequently.16–18
However, the frequency of this mode of transmission in natural
populations of animals, or humans, is less clear. PCR based stud-
ies on the transmission of T. gondii in several mammalian species,
e.g., mice, woodmice17,19–21 and sheep22–25 have suggested that
congenital transmission may be occurring at a higher frequency
than previously thought. Although higher frequencies of congeni-
tal transmission are reported in these studies, in many cases
there seems to be no measurable disease effect on the neonates
in these species. This might suggest that congenital infection
may result in apparently healthy carriers. There is some debate,
however, as to the generality and importance of these results –
especially in sheep.26–28
There are some challenges in measuring congenital transmis-
sion rates in natural human populations in ways that are not det-
rimental to the mother or neonate. The standard approach is to
measure the seroprevalence using a variety of serological
approaches.1 However, some studies have suggested that more
sensitive techniques, such as PCR or parasite detection by bio-
assay, are capable of detecting parasites in seronegative indivi-
duals (e.g., in rodents,29,30 pigs31 and humans32). In the PCR
based studies on sheep,22,23 the measurement of congenital
transmission was conducted utilising umbilical cord tissue as a
proxy for neonatal tissue. In those studies, comparison of PCR
detection of Toxoplasma DNA in umbilical cord tissue with
internal tissues (brain) from infected and uninfected aborted
lambs showed very strong agreement. These results indicated
that PCR positive umbilical cord tissue was a very good predictor
for infection of the brain. This offers the possibility of using a simi-
lar approach to investigate congenital transmission in humans.
Little is known about congenital or general T. gondii infection
in humans in Libya. A study of 4280 people from Tripoli was
conducted in 1987 and showed prevalence of 51.6% (1032/
2000) in adult males, 43.3% (130/300) in adult females and
43.7% (865/1980) in schoolchildren.33 While another study, con-
ducted speciﬁcally on pregnant women in Benghazi (n=369),
found that 47.4% (175/369) were infected with T. gondii.34 To our
knowledge, no studies have been conducted on congenital trans-
mission in humans in Libya. The objectives of this study were,
ﬁrst, to use PCR detection of T. gondii DNA as a tool to investigate
the presence of T. gondii in umbilical cord tissue at birth to gain
an assessment of possible congenital transmission and, secondly,
to investigate the relationship between presence of T. gondii DNA
and clinical or demographic history.
Materials and methods
Sample collection and ethical approval
A total of 272 mothers were recruited during antenatal consul-
tations at Misurata Central Hospital, Libya, in the period prior to
the Libyan crisis (2011) when civil war broke out. The participat-
ing mothers originated from several cities across the West of
Libya (Misurata n=235, Zliten n=17, Tawarga n=9, Al Khums
n=6, Sirte n=2, Qaminis n=1, Tripoli n=1, unknown location
n=1). Ethical procedures followed local Libyan regulations at the
Hospital and both informed patient consent and sample collec-
tion was overseen by one of the authors (MSE, Consultant
Obstetrician) but followed protocols approved for a parallel study
in the UK which was awarded ethical approval by the NHS
National Research Ethics Service (ref O5/Q1409/105). University
of Salford ethical approval was given by the Research Governance
and Ethics Committee, RGEC04/16, and the Research Ethics Panel,
REPN09/102. Informed consent was obtained from mothers during
antenatal sessions to allow collection of discarded umbilical cord
tissue, allow completion of a questionnaire and allow informa-
tion to be obtained from the clinical notes concerning the cur-
rent birth. Both written information (translated into Arabic) and
verbal explanations were provided to ensure understanding and
subjects were coded to ensure anonymity with respect to sam-
ples. Subjects were free to withdraw at any stage in the con-
sent, collection or post collection process. At collection, samples
containing 1 cm3 of tissue (i.e., umbilical cord) were collected
aseptically and washed using sterile saline to remove any
maternal ﬂuids. Using sterile scissors, they were sheared into
small pieces and placed into tubes containing 400 µl of lysis buf-
fer (0·1M Tris-HCl [pH 8·0], 0·2M NaCl, 5mM EDTA, 0·4% SDS),
4 µl of Proteinase K (50mg/ml) and the contents were mixed
thoroughly using a vortex for a few seconds. The tube was then
incubated overnight at 56°C to assist with cell lysis and the
crude DNA extract was then stored at −20°C until further puriﬁ-
cation. Further DNA puriﬁcation was carried out using phenol/
chloroform/isoamyl alcohol as previously described.22 Puriﬁed
DNA was tested by PCR using primers to the mammalian tubulin
gene to ensure the suitability of the DNA for PCR as previously
described.22 Appropriate protocols were used at each stage of
the DNA puriﬁcation and any subsequent PCR ampliﬁcations to
prevent cross-contamination as described previously.21,23,25,35
PCR detection of T. gondii
Detection of T. gondii was carried out using a nested PCR ampliﬁ-
cation of both surface antigen gene 1 (sag 1) as described previ-
ously24,36 and surface antigen gene 3 (sag 3)37 with subsequent
modiﬁcations.38 Pure T. gondii DNA from RH, Martin, 17695 and
COR strains were used as positive controls in all PCR experiments.
All samples were tested a minimum of three times with a PCR to
detect the sag 1 gene and considered positive when three suc-
cessful PCR ampliﬁcations were achieved. Occasional or sporadic
positive reactions were retested and considered negative if they
could not be ampliﬁed to satisfy the three successful ampliﬁca-
tion criteria. Samples found to be positive using the sag 1 PCR cri-
teria were also conﬁrmed using sag 3 PCR which ampliﬁes from
an independent gene locus. Samples negative for sag 1 PCR were
also conﬁrmed as negative by sag 3 PCR.
Statistical analysis
Statistical associations were carried out using 2×2 contingency
tables, with Fisher’s exact test. Correlation tests involving classes
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of data (e.g., age and weight classes) were carried out using a
rank correlation test (Spearman’s). Comparisons of observed with
expected data were carried out using χ2 analysis on Microsoft
Excel® spreadsheet software (Microsoft Corp., Redmond, WA,
USA). A p-value of less than 0.05 was used to indicate statistical
signiﬁcance.
Results
A total of 272 Libyan mothers consented to participate in this
study to investigate the frequency of detection of T. gondii DNA
in foetal-derived umbilical cord tissue at birth. Maternal age
ranges, at the time of the current birth, varied from 17 to 45
years, with a median age of 27 years (IQR 24–32 years). This
cohort of mothers gave birth to 276 babies (268 singletons
and eight twins). Of the newborns, 51.1% (141/276) were
male, 47.8% (132/276) were female and 1.1% (3/276) had unre-
corded gender in the available clinical records. Furthermore, ﬁve
pregnancies (1.8%) were unsuccessful resulting in intrauterine
foetal death of the neonate (all singletons in this instance: three
male and two females). The subsequent determination of cause
of death of these neonates was not recorded in the clinical
notes made available to the study team. Clinical records were
used to determine historical childbirth data, including live and
miscarried babies for each mother. Historical data from only
271 mothers could be obtained. This cohort of mothers had a
varied history of pregnancies (including miscarried births) ran-
ging between 1 and 15 (median, 3; IQR 1–5; n=271) births per
mother. Sixty of the mothers had had one or more miscarriages
(including the ﬁve recorded from the current cohort of births)
totalling the loss of 90 potential neonates. The number of mis-
carriages per mother ranged from 0 (n=211) to between one
and ﬁve (median, 1; IQR 1–2; n=60). Four of the ﬁve current mis-
carriages recorded in this study were ﬁrst time miscarriages
while the other mother had also miscarried once previously, but
had previously also had six successful births.
The risk of miscarriage with maternal age is presented in
Table 1. The rate of miscarriage in current (1.8%, 5/272) and
previous pregnancies was high with 21.7% (60/272) mothers
experiencing miscarriage at some point. A strong positive cor-
relation between the age class of the mothers and the pro-
portion of mothers with miscarriages was observed (correlation
co-efﬁcient=0.88, n=7, p<0.05).
T. gondii DNA was detected in 27 of the 276 foetal-derived
umbilical cord samples (Table 2), representing the 272 pregnan-
cies. This gave a detection prevalence of 9.9% (27/272) of preg-
nancies (95% CI 6.8–13.9%). Of the successful pregnancies,
resulting in the birth of live babies, 10.1% (27/267) of foetal-
derived umbilical cord tissue showed positive detection of
T. gondii DNA. T. gondii DNA was not detected in the umbilical
cord of any of the ﬁve miscarried neonates. Therefore, no associ-
ation was found between presence of T. gondii DNA and unsuc-
cessful pregnancies (p=1.00). Of 273 newborns with available
gender information, 9.2% (13/141) males and 10.6% (14/132)
females were Toxoplasma positive and there was no signiﬁcant
effect of gender on T. gondii DNA presence (p=0.84). To investi-
gate whether a history of miscarriage was associated with pres-
ence of T. gondii DNA in the foetal umbilical cord tissue, clinical
records were examined. Of the 27 tissue samples positive for
T. gondii DNA, six were neonates from mothers that had suf-
fered at least one historical miscarriage. There was no associ-
ation between history of previous miscarriage and T. gondii
positivity (p=0.81) nor total miscarriage history (i.e., including
the current miscarriage) (p=1.00). The birthweight of the cohort
of babies ranged from 1.3 kg to 5 kg. To investigate whether there
was any association between T. gondii positivity and weight of
baby at birth, newborns were categorised into weight classes,
and there was no signiﬁcant difference (χ2=10.4; df=6; p=0.89)
in frequency of T. gondii positivity in difference weight classes.
Table 1. History of maternal miscarriage with respect to maternal age
Age Total Current pregnancy Previous pregnancies All pregnancies
Class Number of mothersa Number of mothers
with miscarriage
% Number of mothers
with miscarriage
% Number of mothers
with miscarriage
%
17–20 23 0 0 2 8.7 2 8.7
21–24 68 1 1.5 4 5.9 5 7.4
25–28 60 0 0 13 21.7 13 21.7
29–32 57 2 3.5 13 22.8 15 26.3
33–36 34 0 0 8 23.5 8 23.5
37–40 25 1 4 11 44 12 48.0
>41 4 1 25 3 75 4 100
Total 271 5 1.8 54 19.9 59 21.7
Columns refer to the current pregnancy (those included in this study), previous pregnancies (covering historical miscarriage data) and all preg-
nancies (current and previous miscarriages combined).
a One mother had no data
Transactions of the Royal Society of Tropical Medicine and Hygiene
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Discussion
The results of the current study indicated that high frequencies
of T. gondii DNA could be detected in the foetal-derived umbil-
ical cord tissue samples of neonates born in Libya. One could
hypothesise that there is a risk of congenital transmission of the
parasite T. gondii occurring from mother to baby. If this is the
case, then there is a signiﬁcant implication. As the transmission
rate is signiﬁcantly higher than previously published estimates
(less than 1 in 1000 live births1,3–5) the implication is that if
parasite transmission is occurring, there are potentially a consid-
erable number of infected babies being born apparently asymp-
tomatically (at least at birth). For example in this study, of
27 T. gondii PCR positive umbilical cord samples from the new-
borns, all were born without miscarriage and without any
observable post-natal defects typically associated with T. gondii
(e.g., hydrocephalus). In fact, some studies have evidenced that,
in general, 80–90% of congenitally infected neonates show no
clinical symptoms at birth.39,40 Although none of the neonates
in this study showed any detectable symptoms (100%, 27/27),
with the relatively small sample size of T. gondii positive neo-
nates, this is not signiﬁcantly different from 80–90% found in
the previously reported studies.39,40
One of the limitations of this study is that detection is based
on PCR and this means that it is possible that it does not
represent living parasites, but parasite DNA molecules. While this
has to be acknowledged, PCR is used widely as a diagnostic tool
for Toxoplasma1 and a wide range of other protozoan parasitic
diseases.41 The presence of parasite DNA does, however, indicate
the presence, and proximity, of the parasite to the foetus during
these pregnancies. It is, perhaps, surprising that none of the
occurrences of miscarriage, seen in this study, appeared to be
associated with the presence of T. gondii DNA. In this cohort of
mothers, the current and historic levels of miscarriage were high.
An important contributing factor to newborn mortality has
often been thought to be the activity of parasites and infectious
agents. Toxoplasma is well known as an agent that causes
miscarriage.5 In this study there was no relationship between
infection and miscarriage. However, the sample size of miscarried
neonates was small (n=5). In the case of unsuccessful pregnancies,
none of the samples showed the presence of the parasite DNA
in the foetal umbilical cord samples. Furthermore, T. gondii was
detected at a higher frequency from the umbilical cord samples of
successful pregnancies (10.1%, 27/267) than would be expected
from previously published estimates on congenital transmission
rates of around 0.1%. This raises the question as to whether live
born babies might be symptomatic or asymptomatic carriers of the
infection. In this study it was not possible to follow up individuals –
this is an important aspect that could be considered in future stud-
ies since congenital infection is often associated with late onset
clinical entities such as ocular toxoplasmosis. However, if congeni-
tally infected children were frequently asymptomatic, and infection
persisted through adulthood, it might offer the opportunity for the
parasite to be passed down vertically or via serial congenital trans-
mission in human populations.26
Few studies have been conducted on vertical transmission
in humans but some evidence for this may be accumulated
from animal species. Watson and Beverley42 studied sheep
Toxoplasma and showed that infection of the placenta corre-
sponded to infection of sacriﬁced live born lambs, thus demon-
strating a link between maternal and foetal infection. Further
recent studies on sheep have revealed that congenital transmis-
sion may be sufﬁcient to explain the maintenance of T. gondii in
natural populations of sheep without requiring new infections
by oocysts secreted by cats.22–25 In the case of these sheep
studies, it was demonstrated that PCR detection of T. gondii
DNA in the umbilical cord was a good indicator of infection
when aborted lamb brain tissue was compared in the same ani-
mal. Nevertheless, a challenge to be encountered in humans (as
may be the case in sheep and other animals) is to understand
whether these individuals are truly asymptomatic carriers of
vertical transmission. In the case of the sheep studies24,25
detailed family pedigrees were established which demonstrated
the occurrence of familial transmission. Further work remains to
be done to determine the role of vertical transmission of
Toxoplasma in humans.
Only a few studies exist on T. gondii prevalence in Libya and
they demonstrate high prevalences (40–50%)33,34 compared to
many other areas of the world. Although updates on these
baseline studies have not been done, the relatively high levels of
detection of T. gondii in the foetal-derived tissues, reported in
this study, are consistent with these high prevalence levels.
Similar high prevalence levels of T. gondii have been reported
in pregnant women from continental Europe: Spain 28.6%,
Sweden 18%, Belgium 48%, Netherlands 35%, Greece 36% and
Germany 63%.2 However, in these other studies only 0.2% con-
genital transmission was shown to be occurring,43 based on
proven clinical cases of infection. In comparison the reported
rate of 9.9% (27/272) reported in this study, based on PCR, is
very high. The difference can be explained by differences in the
detection and diagnostic systems used but interestingly may
suggest higher levels of transmission of parasites than appear
as clinically proven cases.
Unlike the current study, previous reports have generally
used serology for the diagnosis of T. gondii in human tissues.
Serology is the classical diagnostic modality consisting of several
tests on which, virtually all Toxoplasma prevalence studies are
carried out43 but a variety of different approaches are used.
Most of these require the determination of antibody cut off prior
Table 2. PCR detection of Toxoplasma gondii DNA in successful and
unsuccessful pregnancies from a collection of 272 mothers
Outcome Successful
pregnancies
Unsuccessful
pregnancies
Total
Number of pregnancies 267 5 272
Number of PCR positives 27 0 27
Total % 10.11 0 9.93
A successful pregnancy was deﬁned as one in which all neonates
were born alive. An unsuccessful pregnancy was described as a
pregnancy in which one or more babies suffered intrauterine foetal
death. In the cases of mothers (n=4) with twin neonates (n=8), all
newborns were T. gondii DNA negative.
S. Z. H. Haq
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to use and there is some variation in standardisation globally.
The gold standard for testing for T. gondii is serology which has
been used by experts in the ﬁeld1 now routinely records the
serological method used and antibody cut-offs when reporting
prevalence studies.4 This enables a judgement of the relative
validity of results. In the current study only molecular methods
were used to detect for congenital transmission in babies. A
possibility exists that, if congenital transmission is being
detected in this study, differences in the approaches to detec-
tion of the parasite may account for these unusually high trans-
mission frequencies. In sheep, Mason et al.,44 demonstrated
that seronegative neonatal lambs could be PCR positive and the
two approaches (serology vs PCR) showed poor agreement
when comparisons were made. This is suggestive that the differ-
ences in measurements of congenital transmission could be
due to differences in the methodology of measurement. Further
work may still be required to establish robust protocols for
investigating congenital transmission frequency.
Clinical cases of congenital infection have been observed to
occur from chronically infected mothers in some rare
instances.5 These may either be caused by reactivation of cysts
or reinfection.11,45–47 It has been suggested26,48 that the nat-
ural state of immunosuppression entered into by the mother
during pregnancy could be hijacked by the parasite. In this case
it could use the opportunity to reactivate from tissue cysts, as
tachyzoites, which then cross the placenta to infect the foetus.
Although most studies report little evidence for reactivation,
some studies suggest this might be a possibility.49–51 Further
work would be required to investigate this question.
There are a number of shortcomings of this study which we
recognise have an inﬂuence on the strength with which the
results can be interpreted. Firstly, while data on historical and cur-
rent miscarriages were collected from records, serological data
on screening/diagnosis of mothers for T. gondii infection was not
conducted. It was therefore, not possible to determine whether
mothers had a chronic infection or sero-converted during preg-
nancy. In the case of those babies with detectable T. gondii DNA,
it is therefore not possible to determine how or at what stage the
mothers became infected. It is not possible, therefore, to address
chronic reactivation versus infection during pregnancy with this
dataset. Furthermore, it was not possible to get access to blood
from the babies and, therefore, not able to conﬁrm diagnosis by
serology. As discussed previously, based on PCR evidence alone it
is not formally possible to conclude that the babies had active
infections. Ideally, future studies should involve early recruitment
of mothers and monitoring of infection throughout pregnancy by
collection of serum samples. Suitable neonatal samples (e.g.,
cord blood) for T. gondii testing would need to be collected to try
to link the PCR positivity with infection in the newborns. Finally, a
long term follow up study of the newborns could provide import-
ant clinical data with respect to the consequences of infection.
Unfortunately, at the time of writing the political difﬁculties in
Libya are likely to make such future studies challenging.
Conclusions
This study shows a high frequency of detection of T. gondii DNA
in umbilical tissue from neonates in Libya although in this study
there was no association with miscarriage. While we recognise
that there are caveats associated with our interpretations, it
raises the possibility that the foetus could be potentially
exposed to T. gondii infection with higher frequency than previ-
ous studies suggested. It also raises questions about the meth-
ods used to detect transmission to the foetus, the importance
and mechanism of congenital transmission and the potential
generation of asymptomatic carriers of vertical transmission in
humans. Future studies are required to explore these important
questions further.
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